Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Pediatrics. 2009 Jul 20;124(2):637–648. doi: 10.1542/peds.2008-2874

TABLE 6.

ORs and 95% CIs Obtained With TORMs of MDI <55

Epoch Epoch, OR (95% CI)

Antenatal Neonatal (First 28 d) 36 wk PMA
Antenatal
 Gestational age 23–24 wk 1.7 (1.00–3.1) 1.4 (0.6–3.0) 1.3 (0.7–2.8)
 Single mother 2.3 (1.5–3.5) 2.3 (1.5–3.5) 2.3 (1.5–3.6)
 Preeclampsia or fetal indication 2.0 (1.01–3.8) 1.9 (0.96–3.8) 1.9 (0.9–3.8)
Neonatal (first 28 d)
 Late bacteremia 1.8 (1.3–2.5) 1.8 (1.3–2.5)
 Pneumothorax 3.7 (2.6–5.4) 3.6 (2.5–5.4)
 NEC ≥ stage II 2.2 (1.3–3.7) 2.1 (1.2–3.7)
36 wk PMA
 CLD without MV 1.1 (0.8–1.4)
 CLD with MV 1.2 (0.7–2.3)

These analyses include only those children without a severe gross motor impairment (GMFCS score < 1). Antenatal epoch includes the following variables: gestational age of 23–24 weeks; gestational age of 25–26 weeks; single mother; complete course of antenatal steroids; cesarean delivery; and delivery for preeclampsia or fetal indications. Neonatal epoch includes the following variables: SNAP-II in the top quartile; MV or high-frequency ventilation at 7 days; late bacteremia; pneumothorax; PIE; Pao2 in the lowest quartile (week 1); Pao2 missing (week 1); transfusions (packed red blood cells); PD; EPPD; ventriculomegaly; echolucent lesion; echodense lesion; NEC stage II or worse; methylxanthine; PDA; and PDA ligation. Thirty-six weeks' PMA epoch includes the following variables: CLD without MV (CMV or high-frequency ventilation) at 36 weeks and CLD with MV.